---
title: "Branded and Biosimilar Ophthalmology"
ocid: "ocds-h6vhtk-058262"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058262"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-058262.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-058262.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-11-24"
---

# Branded and Biosimilar Ophthalmology

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-h6vhtk-058262

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058262)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-058262.json)

## Summary

The public procurement process conducted by The Common Services Agency, commonly known as NHS National Services Scotland (NSS), focuses on the supply of branded and biosimilar ophthalmology products. It falls under the pharmaceutical industry category and is aimed at NHS Scotland. The process pertains to a range of goods including Aflibercept, Ranibizumab, and Faricimab. The procurement method adopted for this process is an open procedure, and as of 24th November 2025, the procurement stage is at the award phase. The procurement includes a framework agreement with potential extensions. The entire contract, with all its lots, is in the region of UKM, covering all entities under the National Health Service (Scotland) Act 1978. Key dates include the signing of contracts on 30th October 2025, with the award period having commenced on 5th September 2025.

This tender presents significant opportunities for businesses involved in the pharmaceutical supply chain, especially those specialising in ophthalmology products. Companies with solid logistics arrangements and competitive pricing strategies could thrive under this framework agreement. Larger pharmaceutical enterprises, like Bayer Plc, as well as SMEs such as Mercury Pharmaceuticals Limited, have already been successful in securing contracts, indicating a range of opportunities for both large and small businesses. The framework supports collaborative engagement through NHS Scotland's Community Benefits Gateway, making this tender an appealing prospect for companies seeking to enhance their business presence in public healthcare procurement and contribute positively to community development initiatives.

## Notice

Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.

### Lot Information

Aflibercept (Eylea(r))

Supply of Aflibercept (Eylea(r)) vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as a single supplier framework to a single Framework Participant.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Aflibercept Biosimilar

Supply of Aflibercept Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to five (5) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Ranibizumab vials and Pre-filled Syringes

Supply of Ranibizumab Branded and Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Faricimab (Vabysmo(r))

Supply of Faricimab vials and Pre-filled Syringes to NHS Scotland. The Authority has not awarded this Framework to any suppliers.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/076640-2025 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 24 Nov 2025 |
| Submission deadline | 5 Sep 2025 |
| Future notice date | Not specified |
| Award date | 30 Oct 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £146,579,216 |
| Lots value | £146,579,217 |
| Awards value | Not specified |
| Contracts value | £20,671,084 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active, Unsuccessful |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 7 |
| Supplier names | BAYER; BIOGEN IDEC; CELLTRION HEALTHCARE UNITED KINGDOM; MD BIOLOGICS; MERCURY PHARMACEUTICALS; SANDOZ; TEVA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 24 Nov 2025 at 16:57 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/076640-2025
- 6 Aug 2025 at 11:10 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/046478-2025

## Notice URLs

- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000791665
- https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-058262. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-058262.json.